...
首页> 外文期刊>European journal of pharmaceutical sciences >Autophagy as a molecular target for cancer treatment
【24h】

Autophagy as a molecular target for cancer treatment

机译:自噬作为癌症治疗的分子靶标

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment. Recent findings revealed a close relationship between autophagy and malignant transformation. However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful. Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism. In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.
机译:自噬是一种进化的分解代谢机制,通过膜 - 贩运途径将内部成分再循环或降解内部成分。 因此,自噬能量为细胞提供可持续的生物分子源和能量,用于在肿瘤微环境如肿瘤微环境下维持稳态。 最近的发现揭示了自噬和恶性转化之间的密切关系。 然而,由于肿瘤存活或细胞死亡中自噬的复杂双重作用,努力开发靶向自噬/癌症关系的有效治疗策略的努力主要是不成功的。 在这里,我们审查了癌症中的自噬的两种面对的作用作为肿瘤抑制剂或作为致癌机制。 从这个意义上讲,我们还审查了在自噬和恶性转型中发挥作用的共同监管途径。 最后,已经讨论了用作自噬抑制剂或诱导剂的抗癌治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号